MedTrace Logo

A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home)

NCT03096119 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1462

Last updated 2018-04-17

No results posted yet for this study

Summary

Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice.

Therefore, we conduct Asia BP@Home study to assess HBP control status in each Asian country and develop an Asian consensus and Asia-specific treatment for hypertension.

Conditions

Interventions

OTHER

home blood pressure measurement

We ask participants to measure their home blood pressure 7 days or more.

Sponsors & Collaborators

  • Jichi Medical University

    lead OTHER

Principal Investigators

  • Kazuomi Kario, MD, PhD · Jichi Medical University School of Medicine

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-06
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03096119 on ClinicalTrials.gov